Evidence map›Paper›PMID 35991817›Full record

ArticleMalawi medical journal : the journal of Medical Association of Malawi2022

Assessment of the dissimilarities of totally 186 countries and regions according to COVID-19 indicators at the end of March 2020.

Handan Ankarali, Unal Uslu, Seyit Ankarali, Sengul Cangur

Abstract read
In one paragraph

Article in Malawi medical journal : the journal of Medical Association of Malawi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Handan AnkaraliDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Istanbul Medeniyet University, Turkey.
Unal UsluDepartment of Histology and Embryology, Faculty of Medicine, Istanbul Medeniyet University, Turkey.
Seyit AnkaraliDepartment of Physiology, Faculty of Medicine, Istanbul Medeniyet University, Turkey.
Sengul CangurDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Duzce University, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study is aimed at evaluating the relationship between the number of days elapsed since a country's first case(s) of coronavirus disease 2019 (COVID-19), the total number of tests conducted, and outbreak indicators such as the total numbers of cases, deaths, and patients who recovered. The study compares COVID-19 indicators among countries and clusters them according to similarities in the indicators. Methods: Descriptive statistics of the indicators were computed and the results were presented in figures and tables. A fuzzy Results: The highest numbers of COVID-19 cases were found in Gibraltar, Spain, Switzerland, Liechtenstein and Italy were also of that order with about 1500 cases per million population. Spain and Italy had the highest total number of deaths, which were about 140 and 165 per million population, respectively. In Japan, where exposure to the causative virus was longer than in most other countries, the total number of deaths per million population was less than 0.5. According to cluster analysis, the total numbers of deaths, patients who recovered, and active cases were higher in Western countries, especially in central and southern European countries, which had the highest numbers when compared with other countries. Conclusion: There may be various reasons for the differences between the clusters obtained by fuzzy

Indexed as

COVID-19Health PolicyHumansQuarantineclusteringCOVID-19outbreaktotal number of casestotal number of deaths

Identifiers

PMID35991817
PMCPMC9356527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.